| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.98e-06 | 120 | 70 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 5.24e-05 | 21 | 70 | 3 | GO:0061676 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 7.21e-05 | 200 | 70 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.55e-04 | 891 | 70 | 11 | GO:0008270 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.35e-04 | 308 | 70 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 7.42e-04 | 428 | 70 | 7 | GO:0015631 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 9.00e-04 | 54 | 70 | 3 | GO:0005246 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 1.74e-08 | 53 | 66 | 6 | GO:0030574 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 9.68e-07 | 24 | 66 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | TTBK2 KIF9 MTRFR GOLGA6C GOLGA6D GOLGA6B MMP1 MMP2 MMP7 MMP8 KLHDC10 | 3.79e-06 | 617 | 66 | 11 | GO:0022411 |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 4.17e-06 | 75 | 66 | 5 | GO:0022617 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 5.21e-06 | 36 | 66 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 7.86e-06 | 148 | 66 | 6 | GO:0032963 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 8.01e-06 | 40 | 66 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 2.47e-05 | 18 | 66 | 3 | GO:0090166 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.63e-05 | 377 | 66 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.68e-05 | 378 | 66 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.74e-05 | 379 | 66 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 2.92e-05 | 19 | 66 | 3 | GO:0060050 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.09e-05 | 113 | 66 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 4.82e-05 | 204 | 66 | 6 | GO:1903008 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 5.29e-05 | 23 | 66 | 3 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 7.07e-05 | 69 | 66 | 4 | GO:0010559 | |
| GeneOntologyBiologicalProcess | Golgi localization | 8.66e-05 | 27 | 66 | 3 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 9.68e-05 | 28 | 66 | 3 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 9.68e-05 | 28 | 66 | 3 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 9.68e-05 | 28 | 66 | 3 | GO:0048313 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.09e-04 | 77 | 66 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 1.26e-04 | 80 | 66 | 4 | GO:1903018 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | FNDC1 LARP4B ABCA2 BBS7 ANGPT4 SRC PRR5 GOLGA6C GOLGA6D GOLGA6B GNAS SLC39A10 NOS1 DNAJC3 | 1.74e-04 | 1458 | 66 | 14 | GO:0051247 |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.74e-04 | 34 | 66 | 3 | GO:0008356 | |
| GeneOntologyBiologicalProcess | response to fluid shear stress | 1.90e-04 | 35 | 66 | 3 | GO:0034405 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | FNDC1 ABCA2 DBNDD1 ANGPT4 SRC PRR5 GOLGA6C GOLGA6D GOLGA6B GNAS SLC39A10 CMYA5 NOS1 DNAJC3 | 2.15e-04 | 1488 | 66 | 14 | GO:0031399 |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 2.25e-04 | 37 | 66 | 3 | GO:0000212 | |
| GeneOntologyBiologicalProcess | organelle assembly | TTBK2 KIF9 NPTX1 MDN1 CELSR2 BBS7 SRC GOLGA6C GOLGA6D GOLGA6B LRRTM1 DNAAF1 | 2.32e-04 | 1138 | 66 | 12 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of molecular function | TTBK2 ABCA2 DBNDD1 SRC GOLGA6C GOLGA6D GOLGA6B RRAD CMYA5 NOS1 DNAJC3 | 3.19e-04 | 1005 | 66 | 11 | GO:0044092 |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 3.66e-04 | 296 | 66 | 6 | GO:0051259 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 3.72e-04 | 106 | 66 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | cellular response to UV-A | 5.44e-04 | 11 | 66 | 2 | GO:0071492 | |
| GeneOntologyBiologicalProcess | head development | 6.42e-04 | 919 | 66 | 10 | GO:0060322 | |
| GeneOntologyBiologicalProcess | hippo signaling | 7.29e-04 | 55 | 66 | 3 | GO:0035329 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | FNDC1 ANGPT4 SRC PRR5 GOLGA6C GOLGA6D GOLGA6B GNAS SLC39A10 NOS1 | 7.46e-04 | 937 | 66 | 10 | GO:0031401 |
| GeneOntologyBiologicalProcess | protein homooligomerization | 7.54e-04 | 224 | 66 | 5 | GO:0051260 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 8.03e-04 | 130 | 66 | 4 | GO:1901655 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 8.09e-04 | 57 | 66 | 3 | GO:0007020 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 8.16e-04 | 228 | 66 | 5 | GO:0043393 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 8.51e-04 | 58 | 66 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 3 signaling pathway | 8.95e-04 | 14 | 66 | 2 | GO:0034139 | |
| GeneOntologyCellularComponent | extracellular matrix | 4.87e-05 | 656 | 68 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.00e-05 | 658 | 68 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.67e-04 | 33 | 68 | 3 | GO:0000137 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.95e-04 | 431 | 68 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | spindle pole | 5.46e-04 | 205 | 68 | 5 | GO:0000922 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 8.07e-04 | 56 | 68 | 3 | GO:0099091 | |
| MousePheno | increased alveolar macrophage number | 2.27e-05 | 14 | 57 | 3 | MP:0014228 | |
| MousePheno | abnormal cerebellar cortex morphology | 2.72e-05 | 300 | 57 | 8 | MP:0004097 | |
| MousePheno | abnormal alveolar macrophage number | 2.82e-05 | 15 | 57 | 3 | MP:0014227 | |
| MousePheno | abnormal dendrite morphology | 4.73e-05 | 237 | 57 | 7 | MP:0008143 | |
| MousePheno | abnormal cerebellar layer morphology | 9.12e-05 | 263 | 57 | 7 | MP:0009956 | |
| MousePheno | abnormal Golgi vesicle transport | 9.37e-05 | 22 | 57 | 3 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 1.22e-04 | 24 | 57 | 3 | MP:0031355 | |
| MousePheno | abnormal cerebellum morphology | 1.68e-04 | 389 | 57 | 8 | MP:0000849 | |
| MousePheno | abnormal Purkinje cell morphology | 1.75e-04 | 204 | 57 | 6 | MP:0000877 | |
| MousePheno | abnormal alveolar macrophage morphology | 1.75e-04 | 27 | 57 | 3 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 1.96e-04 | 28 | 57 | 3 | MP:0009833 | |
| MousePheno | abnormal renal water reabsorption | 2.42e-04 | 6 | 57 | 2 | MP:0010108 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 2.64e-04 | 220 | 57 | 6 | MP:0000875 | |
| MousePheno | abnormal metencephalon morphology | 2.82e-04 | 420 | 57 | 8 | MP:0000847 | |
| MousePheno | absent acrosome | 2.93e-04 | 32 | 57 | 3 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 3.22e-04 | 33 | 57 | 3 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 3.52e-04 | 34 | 57 | 3 | MP:0020849 | |
| MousePheno | abnormal neurite morphology | 3.98e-04 | 442 | 57 | 8 | MP:0008415 | |
| MousePheno | abnormal liver parenchyma morphology | 4.48e-04 | 243 | 57 | 6 | MP:0008986 | |
| MousePheno | abnormal leukocyte migration | 5.06e-04 | 162 | 57 | 5 | MP:0003156 | |
| MousePheno | abnormal hepatocyte morphology | 5.65e-04 | 166 | 57 | 5 | MP:0000607 | |
| MousePheno | abnormal renal water transport | 5.77e-04 | 9 | 57 | 2 | MP:0011443 | |
| MousePheno | abnormal inflammatory response | SRC PKD1 KPRP MMP1 MMP2 GNAS MMP7 MMP8 KLHDC10 BCR MUC4 NOS1 DNAJC3 SBSN | 6.14e-04 | 1310 | 57 | 14 | MP:0001845 |
| MousePheno | abnormal social investigation | 6.47e-04 | 171 | 57 | 5 | MP:0001360 | |
| MousePheno | abnormal motor coordination/balance | ABCA2 SHANK2 SRC GAS1 GOLGA6C GOLGA6D GOLGA6B GRXCR1 MTCL1 GNAS NOS1 | 6.90e-04 | 873 | 57 | 11 | MP:0001516 |
| MousePheno | abnormal renal water homeostasis | 7.20e-04 | 10 | 57 | 2 | MP:0011444 | |
| MousePheno | decreased sperm progressive motility | 7.28e-04 | 100 | 57 | 4 | MP:0020451 | |
| MousePheno | abnormal hindbrain morphology | 7.34e-04 | 485 | 57 | 8 | MP:0000841 | |
| MousePheno | abnormal sperm progressive motility | 7.56e-04 | 101 | 57 | 4 | MP:0020450 | |
| Domain | PG_binding_1 | 5.23e-11 | 20 | 65 | 6 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 5.23e-11 | 20 | 65 | 6 | IPR002477 | |
| Domain | M10A_MMP | 1.35e-10 | 23 | 65 | 6 | IPR033739 | |
| Domain | Pept_M10A | 1.35e-10 | 23 | 65 | 6 | IPR021190 | |
| Domain | Peptidase_M10 | 1.80e-10 | 24 | 65 | 6 | PF00413 | |
| Domain | ZnMc | 6.26e-10 | 29 | 65 | 6 | SM00235 | |
| Domain | Peptidase_Metallo | 6.26e-10 | 29 | 65 | 6 | IPR006026 | |
| Domain | Pept_M10A_Zn_BS | 1.28e-09 | 15 | 65 | 5 | IPR021158 | |
| Domain | CYSTEINE_SWITCH | 5.73e-09 | 41 | 65 | 6 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 7.73e-09 | 43 | 65 | 6 | IPR001818 | |
| Domain | Hemopexin-like_dom | 1.40e-08 | 23 | 65 | 5 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 1.40e-08 | 23 | 65 | 5 | IPR018487 | |
| Domain | Hemopexin | 1.40e-08 | 23 | 65 | 5 | PF00045 | |
| Domain | HEMOPEXIN | 1.40e-08 | 23 | 65 | 5 | PS00024 | |
| Domain | - | 1.40e-08 | 23 | 65 | 5 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 1.40e-08 | 23 | 65 | 5 | PS51642 | |
| Domain | HX | 1.40e-08 | 23 | 65 | 5 | SM00120 | |
| Domain | Hemopexin_CS | 3.07e-07 | 17 | 65 | 4 | IPR018486 | |
| Domain | MetalloPept_cat_dom | 3.71e-07 | 81 | 65 | 6 | IPR024079 | |
| Domain | - | 3.71e-07 | 81 | 65 | 6 | 3.40.390.10 | |
| Domain | Pept_M10A_stromelysin-type | 3.94e-07 | 18 | 65 | 4 | IPR016293 | |
| Domain | ZINC_PROTEASE | 1.15e-06 | 98 | 65 | 6 | PS00142 | |
| Domain | GOLGA2L5 | 3.16e-05 | 18 | 65 | 3 | PF15070 | |
| Domain | Golgin_A | 3.16e-05 | 18 | 65 | 3 | IPR024858 | |
| Domain | Small_GTPase_GEM/REM/Rad | 7.12e-05 | 4 | 65 | 2 | IPR017358 | |
| Domain | - | 7.12e-05 | 4 | 65 | 2 | 1.10.101.10 | |
| Domain | PAS_fold_3 | 2.88e-03 | 23 | 65 | 2 | IPR013655 | |
| Domain | PAS_3 | 2.88e-03 | 23 | 65 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 3.13e-03 | 24 | 65 | 2 | IPR000700 | |
| Domain | PAC | 3.67e-03 | 26 | 65 | 2 | PS50113 | |
| Domain | hEGF | 4.25e-03 | 28 | 65 | 2 | PF12661 | |
| Domain | - | 4.43e-03 | 95 | 65 | 3 | 2.60.120.200 | |
| Domain | LRR | 5.28e-03 | 201 | 65 | 4 | PS51450 | |
| Domain | PAS | 5.53e-03 | 32 | 65 | 2 | SM00091 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 7.38e-10 | 29 | 51 | 6 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 9.20e-10 | 30 | 51 | 6 | M39652 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.39e-08 | 46 | 51 | 6 | M46450 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.28e-06 | 53 | 51 | 5 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.29e-06 | 64 | 51 | 5 | M26953 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 5.75e-06 | 33 | 51 | 4 | M26976 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.02e-05 | 38 | 51 | 4 | MM14611 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.53e-05 | 114 | 51 | 5 | MM14571 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 7.51e-05 | 23 | 51 | 3 | MM14620 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 8.23e-05 | 64 | 51 | 4 | MM15601 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.04e-04 | 68 | 51 | 4 | M39456 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.46e-04 | 140 | 51 | 5 | M587 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 4.01e-04 | 40 | 51 | 3 | M39798 | |
| Pathway | WP_BLADDER_CANCER | 4.01e-04 | 40 | 51 | 3 | M39523 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 4.97e-04 | 43 | 51 | 3 | M39788 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 6.07e-04 | 46 | 51 | 3 | M198 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 9.59e-04 | 439 | 51 | 7 | MM15595 | |
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 3.88e-12 | 22 | 70 | 6 | 23421805 | |
| Pubmed | Matrix metalloproteinases: structures, evolution, and diversification. | 7.51e-11 | 5 | 70 | 4 | 9737711 | |
| Pubmed | 1.23e-10 | 16 | 70 | 5 | 20484597 | ||
| Pubmed | 5.24e-10 | 7 | 70 | 4 | 25770908 | ||
| Pubmed | 7.32e-10 | 22 | 70 | 5 | 10419448 | ||
| Pubmed | Characterization of opticin digestion by proteases involved in osteoarthritis development. | 1.05e-09 | 8 | 70 | 4 | 23845380 | |
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 1.88e-09 | 9 | 70 | 4 | 10986281 | |
| Pubmed | MDN1 SHANK2 LRCH2 CELSR2 PAK5 SRC GOLGA6C GOLGA6D GOLGA6B MTCL1 LRRTM1 BCR NOS1 TRIM3 | 6.49e-09 | 963 | 70 | 14 | 28671696 | |
| Pubmed | MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. | 7.81e-09 | 3 | 70 | 3 | 26301605 | |
| Pubmed | Expression of Matrix Metalloproteinases in Intraductal Papillary Mucinous Neoplasm of the Pancreas. | 7.81e-09 | 3 | 70 | 3 | 31366549 | |
| Pubmed | 2.69e-08 | 16 | 70 | 4 | 37701782 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 21432777 | ||
| Pubmed | Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. | 3.12e-08 | 4 | 70 | 3 | 25352026 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 28944430 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 19303106 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 25263962 | ||
| Pubmed | Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer. | 3.12e-08 | 4 | 70 | 3 | 15375490 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 22936257 | ||
| Pubmed | Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. | 1.55e-07 | 6 | 70 | 3 | 16940985 | |
| Pubmed | Matrix metalloproteinase polymorphisms and bladder cancer risk. | 1.55e-07 | 6 | 70 | 3 | 17178858 | |
| Pubmed | Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. | 1.55e-07 | 6 | 70 | 3 | 19132754 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 17181997 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 7998967 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 19643940 | ||
| Pubmed | Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. | 1.55e-07 | 6 | 70 | 3 | 17473191 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 12034345 | ||
| Pubmed | 2.18e-07 | 26 | 70 | 4 | 19474315 | ||
| Pubmed | Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. | 2.72e-07 | 7 | 70 | 3 | 8921407 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 17307908 | ||
| Pubmed | Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. | 2.72e-07 | 7 | 70 | 3 | 10859319 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 17564313 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 8216228 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 17607721 | ||
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 16356191 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 18713744 | ||
| Pubmed | 8.44e-07 | 36 | 70 | 4 | 20587546 | ||
| Pubmed | 1.30e-06 | 40 | 70 | 4 | 30578393 | ||
| Pubmed | 1.44e-06 | 41 | 70 | 4 | 30022023 | ||
| Pubmed | Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors. | 1.59e-06 | 42 | 70 | 4 | 24210661 | |
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 12149192 | ||
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 2.20e-06 | 13 | 70 | 3 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 2.20e-06 | 13 | 70 | 3 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 2.20e-06 | 13 | 70 | 3 | 32873390 | |
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 21552007 | ||
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 2.20e-06 | 13 | 70 | 3 | 28028212 | |
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 12815621 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 2.20e-06 | 13 | 70 | 3 | 29128360 | |
| Pubmed | The ATPase activity of Asna1/TRC40 is required for pancreatic progenitor cell survival. | 2.51e-06 | 47 | 70 | 4 | 29180572 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 37831422 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 16236725 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 2.80e-06 | 14 | 70 | 3 | 27226319 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 25636537 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 2.80e-06 | 14 | 70 | 3 | 33543287 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 3.49e-06 | 15 | 70 | 3 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 3.49e-06 | 15 | 70 | 3 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 3.49e-06 | 15 | 70 | 3 | 17189423 | |
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 3.49e-06 | 15 | 70 | 3 | 28509431 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 3.49e-06 | 15 | 70 | 3 | 26165940 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 3.49e-06 | 15 | 70 | 3 | 17204322 | |
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 16413118 | ||
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 18639653 | ||
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 26083584 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19134348 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34561981 | ||
| Pubmed | HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. | 3.99e-06 | 2 | 70 | 2 | 11220743 | |
| Pubmed | Evaluation of MMP-7 A-181G and MMP-2 C-735T polymorphisms in healthy population from western Iran. | 3.99e-06 | 2 | 70 | 2 | 26950446 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25181017 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 38097740 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26293377 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21531813 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21756063 | ||
| Pubmed | Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. | 3.99e-06 | 2 | 70 | 2 | 19708869 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23893803 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21637818 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23676485 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31067818 | ||
| Pubmed | Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma. | 3.99e-06 | 2 | 70 | 2 | 31932027 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19345347 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20192597 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30689319 | ||
| Pubmed | Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma. | 3.99e-06 | 2 | 70 | 2 | 12684625 | |
| Pubmed | Correlations of MMP-1 and MMP-2 gene polymorphisms with essential hypertension. | 3.99e-06 | 2 | 70 | 2 | 31124635 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19460733 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25549795 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29532899 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27412345 | ||
| Pubmed | [Polymorphism of metalloproteinases MMP-1 and MMP-2 in risk of laryngeal cancer]. | 3.99e-06 | 2 | 70 | 2 | 23164104 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30328228 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21784671 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20979817 | ||
| Pubmed | MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. | 3.99e-06 | 2 | 70 | 2 | 18447576 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23644699 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16293618 | ||
| Pubmed | Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13. | 3.99e-06 | 2 | 70 | 2 | 17017992 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20826916 | ||
| Pubmed | Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells. | 3.99e-06 | 2 | 70 | 2 | 16168111 | |
| Pubmed | Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer. | 3.99e-06 | 2 | 70 | 2 | 30627896 | |
| Pubmed | 4.29e-06 | 16 | 70 | 3 | 16399995 | ||
| Interaction | MMP8 interactions | 2.20e-08 | 25 | 70 | 5 | int:MMP8 | |
| Interaction | MMP27 interactions | 4.32e-08 | 11 | 70 | 4 | int:MMP27 | |
| Interaction | MMP9 interactions | 1.19e-07 | 67 | 70 | 6 | int:MMP9 | |
| Interaction | MMP1 interactions | 1.75e-07 | 37 | 70 | 5 | int:MMP1 | |
| Interaction | MMP16 interactions | 3.94e-07 | 18 | 70 | 4 | int:MMP16 | |
| Interaction | MMP24 interactions | 4.97e-07 | 19 | 70 | 4 | int:MMP24 | |
| Interaction | MMP2 interactions | 5.71e-07 | 87 | 70 | 6 | int:MMP2 | |
| Interaction | MMP10 interactions | 3.42e-06 | 30 | 70 | 4 | int:MMP10 | |
| Interaction | BCAN interactions | 7.23e-06 | 36 | 70 | 4 | int:BCAN | |
| Interaction | CLRN3 interactions | 1.12e-05 | 13 | 70 | 3 | int:CLRN3 | |
| Interaction | MMP7 interactions | 1.95e-05 | 46 | 70 | 4 | int:MMP7 | |
| Interaction | ACAN interactions | 5.89e-05 | 22 | 70 | 3 | int:ACAN | |
| Interaction | TFPI interactions | 1.11e-04 | 27 | 70 | 3 | int:TFPI | |
| Interaction | ADRB3 interactions | 1.77e-04 | 6 | 70 | 2 | int:ADRB3 | |
| Interaction | CEACAM21 interactions | 1.81e-04 | 81 | 70 | 4 | int:CEACAM21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.27e-05 | 107 | 70 | 4 | chr11q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 8.80e-04 | 122 | 70 | 3 | chr15q24 | |
| Cytoband | 15q24.2 | 1.10e-03 | 32 | 70 | 2 | 15q24.2 | |
| Cytoband | 11q22.3 | 2.08e-03 | 44 | 70 | 2 | 11q22.3 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.88e-11 | 24 | 47 | 6 | 891 | |
| GeneFamily | RGK type GTPase family | 3.96e-05 | 4 | 47 | 2 | 1260 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-06 | 172 | 70 | 5 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.00e-05 | 182 | 70 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 190 | 70 | 5 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 190 | 70 | 5 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 192 | 70 | 5 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 196 | 70 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 197 | 70 | 5 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-05 | 197 | 70 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.59e-05 | 132 | 70 | 4 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 157 | 70 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.12e-04 | 158 | 70 | 4 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 167 | 70 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 167 | 70 | 4 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 167 | 70 | 4 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.42e-04 | 168 | 70 | 4 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 170 | 70 | 4 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 170 | 70 | 4 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 175 | 70 | 4 | f2c3e0f728a43d6988e793c8a50c964f7447db82 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 176 | 70 | 4 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 176 | 70 | 4 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 70 | 4 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 70 | 4 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 70 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.85e-04 | 180 | 70 | 4 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-04 | 181 | 70 | 4 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-04 | 182 | 70 | 4 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.93e-04 | 182 | 70 | 4 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.97e-04 | 183 | 70 | 4 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-04 | 183 | 70 | 4 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.01e-04 | 184 | 70 | 4 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 184 | 70 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 185 | 70 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 185 | 70 | 4 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.10e-04 | 186 | 70 | 4 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 186 | 70 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 186 | 70 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.14e-04 | 187 | 70 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-04 | 188 | 70 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-04 | 188 | 70 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.18e-04 | 188 | 70 | 4 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 2.23e-04 | 189 | 70 | 4 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.23e-04 | 189 | 70 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-04 | 189 | 70 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.27e-04 | 190 | 70 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-04 | 190 | 70 | 4 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 190 | 70 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 190 | 70 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 191 | 70 | 4 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.32e-04 | 191 | 70 | 4 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-04 | 191 | 70 | 4 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 191 | 70 | 4 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.32e-04 | 191 | 70 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-04 | 193 | 70 | 4 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-04 | 193 | 70 | 4 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-04 | 194 | 70 | 4 | c9e589fe7df6a9b377654581a2aebb607cbb03b9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 194 | 70 | 4 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.46e-04 | 194 | 70 | 4 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 194 | 70 | 4 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 195 | 70 | 4 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.51e-04 | 195 | 70 | 4 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-04 | 195 | 70 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 2.56e-04 | 196 | 70 | 4 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 2.56e-04 | 196 | 70 | 4 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 196 | 70 | 4 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 2.56e-04 | 196 | 70 | 4 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 196 | 70 | 4 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 197 | 70 | 4 | 7d97c2d51a543c02d679e9257b22d0581e73a11d | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.61e-04 | 197 | 70 | 4 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 197 | 70 | 4 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 197 | 70 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 197 | 70 | 4 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.61e-04 | 197 | 70 | 4 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 197 | 70 | 4 | 671d6b5effbac2dd71d18f48d23c523738db1828 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 197 | 70 | 4 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.61e-04 | 197 | 70 | 4 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 197 | 70 | 4 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.66e-04 | 198 | 70 | 4 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.66e-04 | 198 | 70 | 4 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.66e-04 | 198 | 70 | 4 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.66e-04 | 198 | 70 | 4 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 198 | 70 | 4 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 198 | 70 | 4 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 198 | 70 | 4 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.66e-04 | 198 | 70 | 4 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-04 | 199 | 70 | 4 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.71e-04 | 199 | 70 | 4 | a207b4891881149d4c50721310690fd794157723 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 199 | 70 | 4 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.71e-04 | 199 | 70 | 4 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 199 | 70 | 4 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 199 | 70 | 4 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 2.76e-04 | 200 | 70 | 4 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.76e-04 | 200 | 70 | 4 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-04 | 200 | 70 | 4 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-04 | 200 | 70 | 4 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.76e-04 | 200 | 70 | 4 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-04 | 200 | 70 | 4 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| Computational | Genes in the cancer module 211. | 6.60e-06 | 11 | 38 | 3 | MODULE_211 | |
| Computational | MMPs. | 5.19e-05 | 21 | 38 | 3 | MODULE_562 | |
| Computational | Genes in the cancer module 371. | 1.00e-04 | 26 | 38 | 3 | MODULE_371 | |
| Computational | Genes in the cancer module 210. | 1.26e-04 | 28 | 38 | 3 | MODULE_210 | |
| Computational | Metal ion (zinc) binding. | 5.22e-04 | 45 | 38 | 3 | MODULE_280 | |
| Drug | DA-125 | 1.13e-10 | 26 | 67 | 6 | CID000114758 | |
| Drug | mercuric acetate | 2.90e-10 | 30 | 67 | 6 | CID000015337 | |
| Drug | malolactomycin D | 4.41e-10 | 32 | 67 | 6 | CID006449115 | |
| Drug | AC1L9M3B | 5.33e-10 | 61 | 67 | 7 | CID000448562 | |
| Drug | (1R,2R,4S,5R)-6-methylolcyclohexane-1,2,3,4,5-pentol | 8.53e-09 | 9 | 67 | 4 | CID011321479 | |
| Drug | CGS 27023A | 8.53e-09 | 9 | 67 | 4 | ctd:C097658 | |
| Drug | benzoyl isothiocyanate | 2.22e-08 | 11 | 67 | 4 | CID000068284 | |
| Drug | 5-mercapto-1,3,4-thiadiazole 13c | 2.44e-08 | 3 | 67 | 3 | CID010030894 | |
| Drug | Hydroxamate 44 | 2.44e-08 | 3 | 67 | 3 | CID010027203 | |
| Drug | Hydroxamate 39 | 2.44e-08 | 3 | 67 | 3 | CID011036991 | |
| Drug | (2S)-2-[(2-nitrobenzyl)-(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyl)amino]propanehydroxamic acid | 2.44e-08 | 3 | 67 | 3 | CID010994933 | |
| Drug | Hydroxamate 36 | 2.44e-08 | 3 | 67 | 3 | CID010500886 | |
| Drug | 5-mercapto-1,3,4-thiadiazole 13b | 2.44e-08 | 3 | 67 | 3 | CID011757336 | |
| Drug | 4-aminophenyl | 2.79e-08 | 62 | 67 | 6 | CID000181201 | |
| Drug | diacerein | 3.08e-08 | 63 | 67 | 6 | CID000026248 | |
| Drug | titanium | 3.67e-08 | 170 | 67 | 8 | CID000023963 | |
| Drug | D 2163 | 6.70e-08 | 14 | 67 | 4 | CID000148203 | |
| Drug | AC1L1GXT | 8.18e-08 | 74 | 67 | 6 | CID000003890 | |
| Drug | A0395 | 8.87e-08 | 75 | 67 | 6 | CID009906466 | |
| Drug | AC1NSU5S | 8.87e-08 | 75 | 67 | 6 | CID005316299 | |
| Drug | carbamoylphosphonic acid | 9.72e-08 | 4 | 67 | 3 | CID013879809 | |
| Drug | 3-hydroxypicolinic acid | 9.72e-08 | 4 | 67 | 3 | ctd:C049246 | |
| Drug | (2S)-2-[(2-nitrobenzyl)-(2,3,4,5,6-pentafluorophenyl)sulfonyl-amino]propanehydroxamic acid | 9.72e-08 | 4 | 67 | 3 | CID011037999 | |
| Drug | pirfenidone | 1.66e-07 | 138 | 67 | 7 | CID000040632 | |
| Drug | beta-sulfone 7f | 2.43e-07 | 5 | 67 | 3 | CID011526076 | |
| Drug | alpha-sulfone 27e | 2.43e-07 | 5 | 67 | 3 | CID011719408 | |
| Drug | MMP-3 inhibitor | 2.43e-07 | 5 | 67 | 3 | CID010549329 | |
| Drug | Hydroxamate 33 | 2.43e-07 | 5 | 67 | 3 | CID010810684 | |
| Drug | beta-sulfone 7e | 2.43e-07 | 5 | 67 | 3 | CID011641261 | |
| Drug | beta-sulfone 7b | 2.43e-07 | 5 | 67 | 3 | CID009867183 | |
| Drug | Hydroxamate 31 | 2.43e-07 | 5 | 67 | 3 | CID011799753 | |
| Drug | Hydroxysulfonamide 66 | 2.43e-07 | 5 | 67 | 3 | CID012635073 | |
| Drug | CTS-1027 | 2.43e-07 | 5 | 67 | 3 | CID003342298 | |
| Drug | CGS 25966 | 2.43e-07 | 5 | 67 | 3 | CID009821883 | |
| Drug | SC-276 | 2.43e-07 | 5 | 67 | 3 | CID009802768 | |
| Drug | alpha-sulfone 35g | 2.43e-07 | 5 | 67 | 3 | CID011705502 | |
| Drug | Hydroxamate 34 | 2.43e-07 | 5 | 67 | 3 | CID010529602 | |
| Drug | beta-sulfone 7d | 2.43e-07 | 5 | 67 | 3 | CID011548264 | |
| Drug | alpha-sulfone 27d | 2.43e-07 | 5 | 67 | 3 | CID011532911 | |
| Drug | alpha-sulfone 27g | 2.43e-07 | 5 | 67 | 3 | CID011561491 | |
| Drug | I01-10485 | 2.43e-07 | 5 | 67 | 3 | CID011009332 | |
| Drug | alpha-sulfone 27b | 2.43e-07 | 5 | 67 | 3 | CID011697282 | |
| Drug | beta-sulfone 7c | 2.43e-07 | 5 | 67 | 3 | CID011613649 | |
| Drug | Hydroxamate 32 | 4.84e-07 | 6 | 67 | 3 | CID010671441 | |
| Drug | Hydroxamate 26 | 4.84e-07 | 6 | 67 | 3 | CID010833334 | |
| Drug | NSC47818 | 4.84e-07 | 6 | 67 | 3 | CID000240910 | |
| Drug | Hydroxysulfonamide 69 | 4.84e-07 | 6 | 67 | 3 | CID010610114 | |
| Drug | NSC-139458 | 4.84e-07 | 6 | 67 | 3 | CID000283995 | |
| Drug | 4-aminoproline | 4.84e-07 | 6 | 67 | 3 | CID000124558 | |
| Drug | Hydroxamate 35 | 4.84e-07 | 6 | 67 | 3 | CID010456675 | |
| Drug | 2-Amino-5-mercapto-1,3,4-thiadiazole | 4.84e-07 | 6 | 67 | 3 | CID002723847 | |
| Drug | Hydroxamate 28 | 4.84e-07 | 6 | 67 | 3 | CID010792025 | |
| Drug | Hydroxamate 12 | 4.84e-07 | 6 | 67 | 3 | CID010594000 | |
| Drug | (2S)-2-[benzyl-(2,3,4,5,6-pentafluorophenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide | 4.84e-07 | 6 | 67 | 3 | CID010694926 | |
| Drug | Hydroxamate 10 | 4.84e-07 | 6 | 67 | 3 | CID010837740 | |
| Drug | Hydroxamate 29 | 4.84e-07 | 6 | 67 | 3 | CID010766622 | |
| Drug | Hydroxamate 8 | 4.84e-07 | 6 | 67 | 3 | CID010758013 | |
| Drug | Hydroxamate 14 | 4.84e-07 | 6 | 67 | 3 | CID010042482 | |
| Drug | (2S)-2-[benzyl(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyl)amino]-N-hydroxy-3-methylbutanamide | 4.84e-07 | 6 | 67 | 3 | CID010696860 | |
| Drug | anti-TIMP-4 | 8.45e-07 | 7 | 67 | 3 | CID004283518 | |
| Drug | hydroxamate 20 | 8.45e-07 | 7 | 67 | 3 | CID011792968 | |
| Drug | CGS 27023A Analog 51 | 8.45e-07 | 7 | 67 | 3 | CID010594938 | |
| Drug | AC1L1DD6 | 9.65e-07 | 179 | 67 | 7 | CID000002299 | |
| Drug | Ro 32-3555 | 1.35e-06 | 8 | 67 | 3 | CID000193987 | |
| Drug | Sc 40827 | 1.35e-06 | 8 | 67 | 3 | CID000127918 | |
| Drug | hydroxamate 11 | 1.35e-06 | 8 | 67 | 3 | CID010001582 | |
| Drug | Marimastat | 1.35e-06 | 8 | 67 | 3 | DB00786 | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A | 1.54e-06 | 192 | 67 | 7 | 7364_UP | |
| Drug | losartan | 1.59e-06 | 378 | 67 | 9 | CID000003961 | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.65e-06 | 194 | 67 | 7 | 4260_UP | |
| Drug | marimastat | 1.71e-06 | 68 | 67 | 5 | CID000119031 | |
| Drug | AC1NRBJE | 5.72e-06 | 152 | 67 | 6 | CID005288446 | |
| Drug | isoflavone | 6.40e-06 | 155 | 67 | 6 | CID000072304 | |
| Drug | FN-439 | 6.82e-06 | 13 | 67 | 3 | CID000004648 | |
| Drug | N-methylmesoporphyrin | 7.05e-06 | 42 | 67 | 4 | CID000444708 | |
| Drug | quinacrine | 7.30e-06 | 243 | 67 | 7 | CID000000237 | |
| Drug | carvedilol | 7.96e-06 | 161 | 67 | 6 | CID000002585 | |
| Drug | (3S)-2-[4-(4-tert-butylphenyl)benzyl]-1,1-diketo-thiazinane-3-carbohydroxamic acid | 8.53e-06 | 2 | 67 | 2 | CID010112621 | |
| Drug | METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID | 8.53e-06 | 2 | 67 | 2 | DB08403 | |
| Drug | Ageladine A | 8.66e-06 | 14 | 67 | 3 | ctd:C482289 | |
| Drug | glycylvaline | 1.02e-05 | 46 | 67 | 4 | CID000097417 | |
| Drug | 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol | 1.08e-05 | 15 | 67 | 3 | ctd:C435044 | |
| Drug | peroxynitrite | 1.35e-05 | 373 | 67 | 8 | CID000104806 | |
| Drug | Melphalan | 1.67e-05 | 276 | 67 | 7 | ctd:D008558 | |
| Drug | dioxane | 1.75e-05 | 278 | 67 | 7 | CID000031275 | |
| Drug | MMI270 | 1.93e-05 | 18 | 67 | 3 | CID000446504 | |
| Drug | glycyl-L-leucine | 1.94e-05 | 54 | 67 | 4 | CID000092843 | |
| Drug | aldosterone | 2.12e-05 | 397 | 67 | 8 | CID000005839 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.23e-05 | 193 | 67 | 6 | 1653_DN | |
| Drug | Hlnl | 2.28e-05 | 19 | 67 | 3 | CID000122155 | |
| Drug | Pz-plgpa | 2.28e-05 | 19 | 67 | 3 | CID000152296 | |
| Drug | 17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 6172_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; HL60; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 2726_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 3700_UP | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 6402_UP | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; PC3; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 5809_UP | |
| Drug | alpha-sulfone 27a | 2.55e-05 | 3 | 67 | 2 | CID009912853 | |
| Drug | AC1L1JRO | 2.55e-05 | 3 | 67 | 2 | CID000005176 | |
| Drug | delta-(3,4-dihydroxyphenyl)-gamma-valerolactone | 2.55e-05 | 3 | 67 | 2 | CID000152432 | |
| Drug | alpha-sulfone 13 | 2.55e-05 | 3 | 67 | 2 | CID011616500 | |
| Disease | immunoglobulin light chain amyloidosis (is_marker_for) | 1.43e-05 | 3 | 65 | 2 | DOID:0080933 (is_marker_for) | |
| Disease | carotid artery disease (is_implicated_in) | 1.52e-05 | 22 | 65 | 3 | DOID:3407 (is_implicated_in) | |
| Disease | osteoarthritis (is_marker_for) | 6.35e-05 | 35 | 65 | 3 | DOID:8398 (is_marker_for) | |
| Disease | stromelysin-2 measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0802095 | |
| Disease | stanniocalcin-1 measurement | 1.33e-04 | 8 | 65 | 2 | EFO_0020753 | |
| Disease | cystic fibrosis, lung disease severity measurement | 1.70e-04 | 9 | 65 | 2 | EFO_0007744, MONDO_0009061 | |
| Disease | hypertension (implicated_via_orthology) | 1.86e-04 | 128 | 65 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 2.13e-04 | 10 | 65 | 2 | DOID:7693 (is_marker_for) | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 2.13e-04 | 10 | 65 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.11e-04 | 12 | 65 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | psoriasis | 3.43e-04 | 273 | 65 | 5 | EFO_0000676 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 3.67e-04 | 13 | 65 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | COVID-19 (is_marker_for) | 3.69e-04 | 63 | 65 | 3 | DOID:0080600 (is_marker_for) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.27e-04 | 14 | 65 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 4.27e-04 | 14 | 65 | 2 | DOID:14004 (is_marker_for) | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 5.62e-04 | 16 | 65 | 2 | DOID:10964 (is_marker_for) | |
| Disease | Oral Submucous Fibrosis | 7.15e-04 | 18 | 65 | 2 | C0029172 | |
| Disease | Neoplasm Invasiveness | 7.36e-04 | 184 | 65 | 4 | C0027626 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 7.98e-04 | 19 | 65 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 1.46e-03 | 101 | 65 | 3 | DOID:1793 (is_marker_for) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.72e-03 | 107 | 65 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 1.81e-03 | 109 | 65 | 3 | C3830362 | |
| Disease | Miscarriage | 1.81e-03 | 109 | 65 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.81e-03 | 109 | 65 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 1.81e-03 | 109 | 65 | 3 | C0000822 | |
| Disease | ceramide measurement | 1.82e-03 | 235 | 65 | 4 | EFO_0010222 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 1.87e-03 | 29 | 65 | 2 | DOID:332 (is_marker_for) | |
| Disease | arteriosclerosis (is_implicated_in) | 2.13e-03 | 31 | 65 | 2 | DOID:2349 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HNGNGGDSGEDLLFG | 196 | Q8IWZ6 | |
| GDIFGAENGAPGEQG | 751 | Q14031 | |
| GQIWPNDGEGAFHGD | 411 | P11274 | |
| AEGNTGDAFGIFPDG | 1036 | Q6V0I7 | |
| GVGHDFPFTINNGTG | 546 | Q9HCU4 | |
| DAESQQGGGGNPFHR | 466 | Q13217 | |
| GEHGSGEQPSGEQAS | 146 | P26436 | |
| GEAGDSGKPGAAFHQ | 266 | Q9BUB4 | |
| APGTGVGGDSHFDDD | 196 | P08253 | |
| PGQGIGGDAHFDAEE | 186 | P22894 | |
| VQGGHQADGPDHDSD | 1081 | Q9Y4B5 | |
| DGTQGGSGENLAPYH | 331 | Q15818 | |
| FGGVEDGPEAEAAGH | 111 | P55042 | |
| GASSHGPGHAEENGF | 111 | Q9P286 | |
| GPGLGGDTHFDEDEN | 186 | Q9H306 | |
| DHEDGGGQETFNATG | 4776 | Q99102 | |
| APGTGLGGDAHFDED | 181 | P09237 | |
| DEEGGENGPADQGFQ | 4991 | Q9NU22 | |
| GDGDEDGPAQQLSGF | 1086 | Q92619 | |
| GQEHQAPGHSEAGGV | 351 | Q8IU57 | |
| GIDGLGDSDGQQNGH | 51 | A8MXD5 | |
| DGGEGQHDGTFEPAT | 396 | Q86UE6 | |
| NGDGDQGHENAALPD | 101 | Q92615 | |
| GTGIPFGESNGNDVH | 171 | Q6PID8 | |
| LGPQGGRGDSNHENS | 141 | Q9UQ05 | |
| GNFSLEHGGLAGPEQ | 291 | Q9UBR4 | |
| PEGSAEGGGVHQQAG | 106 | Q9HBQ8 | |
| LAQHGGGDAPGAAAA | 76 | P54826 | |
| VDGHLVGEPEGQNFG | 466 | Q9HAQ2 | |
| GGGHSPGDSQYQELA | 61 | A6NDN3 | |
| GNGPQHAYDDGQEAG | 156 | P29475 | |
| QVQDSFHEDGSGGEP | 786 | Q8IUM7 | |
| EQQDAGDFPEAGGGG | 21 | P17658 | |
| AALGVPAQGTGDNGH | 21 | Q9H9R9 | |
| DGENNGHGEVASFPG | 196 | Q6UUV7 | |
| QQVESPTGAGAGGDH | 1111 | Q4ZHG4 | |
| GSHGNEVGNASPEVN | 3356 | Q8N3K9 | |
| HLGGEQSQAGAPEGS | 31 | Q8IX06 | |
| GGGHSPGDSQYQELA | 61 | A6NDK9 | |
| NGFNGEGGEEDPQAA | 66 | P63092 | |
| AEGPASGEGHAGNLA | 1346 | Q9BZC7 | |
| QGFGDPAGEHWLGNE | 351 | Q9Y264 | |
| HSLDDGDQGQGADAP | 301 | A1A5D9 | |
| GDNGSGGHFAHPRED | 66 | Q8NEP3 | |
| GGGHSPGDSQYQELA | 61 | P0CG33 | |
| FPERRGQDGHGDQGN | 551 | Q5T749 | |
| GQDGHGDQGNAFAGV | 556 | Q5T749 | |
| GDGDNEEHGFCPVGQ | 786 | Q9ULF5 | |
| PGVHEAGKEAGQFGQ | 446 | Q6UWP8 | |
| AGDTGQPAEDSDHGG | 636 | Q9HBR0 | |
| KNHGPDSGIGSDNGE | 341 | Q5VUJ6 | |
| QAGHGLGPEEDGFSL | 3441 | P98161 | |
| FQGDHNDGLGNAFDG | 186 | Q9H239 | |
| VHTPISQNGGDGQEG | 156 | Q9HB19 | |
| AENVHGAGGGAFPAS | 21 | P12931 | |
| GLVHAAGPGQDSGSQ | 271 | Q96ER9 | |
| GDHRDNSPFDGPGGN | 166 | P03956 | |
| NPVQEHEAEGAAAGG | 261 | P85299 | |
| LHVNGFNGEGGEEDP | 706 | Q5JWF2 | |
| EPGGAHGESGGFQVV | 31 | P48764 | |
| AEGDPQGQGLHDGSF | 1036 | Q8TCU6 | |
| HFVGGAEASAPGEAG | 1156 | Q9UPX8 | |
| GEHAGGQEFGLEGSA | 801 | Q0VD83 | |
| EGETQFGFPNAAGNH | 771 | P98169 | |
| EEQFVKGHGPGGQAT | 61 | Q9H3J6 | |
| ALAGAVNQHGGFEPA | 281 | Q9NRA0 | |
| ANTPEQADGGGSNGF | 521 | Q6IQ55 | |
| AGTFGGLQGDSAHEP | 131 | Q8IYK8 | |
| GLFPGEGQQAASHSG | 1491 | O43151 | |
| PHSEGASQEDGAQGA | 56 | O95201 | |
| SHGEGNGQFNAPTGV | 661 | O75382 | |
| AQHGDGLGAAGGEEP | 301 | Q6DD87 |